Archive | 2009-2017 Life Science Portfolios

Immucor(BLUD) Profits Up but Stock Down 8 %

Immucor (BLUD) a global leader in providing instrument-reagent systems to the blood transfusion industry ¬†delivered more than expected financial results for the 3rd Quarter of fiscal 2010 ended February 28. Revenue of $80.5M was up 7% from prior year quarter. Gross margin was 69.2% compared to prior year quarter of 71.4%. Diluted earnings per share […]

Continue Reading 0

2009-2010 Life Sciences Portfolio

The Raygent Model Portfolio was created in February 2009 and will be updated by the end of March 2010.The 14 month YTD performance is up 25%. New buys over past four months were Sequenom (SQNM) and SeraCare (SRLS). Currently under review are Immucor (BLUD) , MicroFluidics (MLFU) , Genomic Health (GHDH) and Genoptix (GXDX). Published […]

Continue Reading 0